These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 19579589)

  • 41. A mouse model of Clostridium difficile-associated disease.
    Chen X; Katchar K; Goldsmith JD; Nanthakumar N; Cheknis A; Gerding DN; Kelly CP
    Gastroenterology; 2008 Dec; 135(6):1984-92. PubMed ID: 18848941
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Surveillance for community-associated Clostridium difficile--Connecticut, 2006.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2008 Apr; 57(13):340-3. PubMed ID: 18385641
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Clostridium difficile-associated diarrhea in heart transplant recipients: is hypogammaglobulinemia the answer?
    Muñoz P; Giannella M; Alcalá L; Sarmiento E; Fernandez Yañez J; Palomo J; Catalán P; Carbone J; Bouza E
    J Heart Lung Transplant; 2007 Sep; 26(9):907-14. PubMed ID: 17845929
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Clostridium difficile associated diarrhea: reliable therapy with vancomycin capsules].
    MMW Fortschr Med; 2012 Sep; 154(16):64-5. PubMed ID: 23045940
    [No Abstract]   [Full Text] [Related]  

  • 45. The search for a better treatment for recurrent Clostridium difficile disease: use of high-dose vancomycin combined with Saccharomyces boulardii.
    Surawicz CM; McFarland LV; Greenberg RN; Rubin M; Fekety R; Mulligan ME; Garcia RJ; Brandmarker S; Bowen K; Borjal D; Elmer GW
    Clin Infect Dis; 2000 Oct; 31(4):1012-7. PubMed ID: 11049785
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Systemic absorption of oral vancomycin in patients with Clostridium difficile infection.
    Rao S; Kupfer Y; Pagala M; Chapnick E; Tessler S
    Scand J Infect Dis; 2011 May; 43(5):386-8. PubMed ID: 21198337
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Prospective, randomized inpatient study of oral metronidazole versus oral metronidazole and rifampin for treatment of primary episode of Clostridium difficile-associated diarrhea.
    Lagrotteria D; Holmes S; Smieja M; Smaill F; Lee C
    Clin Infect Dis; 2006 Sep; 43(5):547-52. PubMed ID: 16886144
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Clostridium difficile-positive stools: a retrospective identification of risk factors.
    Howitt JR; Grace JW; Schaefer MG; Dolder C; Cannella C; Schaefer RS
    Am J Infect Control; 2008 Sep; 36(7):488-91. PubMed ID: 18786452
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Interruption of recurrent Clostridium difficile-associated diarrhea episodes by serial therapy with vancomycin and rifaximin.
    Johnson S; Schriever C; Galang M; Kelly CP; Gerding DN
    Clin Infect Dis; 2007 Mar; 44(6):846-8. PubMed ID: 17304459
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The outcome of surgery in fulminant Clostridium difficile colitis.
    Koss K; Clark MA; Sanders DS; Morton D; Keighley MR; Goh J
    Colorectal Dis; 2006 Feb; 8(2):149-54. PubMed ID: 16412077
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Community-onset Clostridium difficile-associated diarrhoea not associated with antibiotic usage--two case reports with review of the changing epidemiology of Clostridium difficile-associated diarrhoea.
    Bauer MP; Goorhuis A; Koster T; Numan-Ruberg SC; Hagen EC; Debast SB; Kuijper EJ; van Dissel JT
    Neth J Med; 2008 May; 66(5):207-11. PubMed ID: 18490799
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Overuse and inappropriate prescribing of proton pump inhibitors in patients with Clostridium difficile-associated disease.
    Choudhry MN; Soran H; Ziglam HM
    QJM; 2008 Jun; 101(6):445-8. PubMed ID: 18411220
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Antibiotic treatment of Clostridium difficile associated diarrhea in adults. A survey of a Cochrane review].
    Dahl EE; Bangsborg J; Nielsen OH
    Ugeskr Laeger; 2006 Apr; 168(17):1631-4. PubMed ID: 16674872
    [No Abstract]   [Full Text] [Related]  

  • 54. Costs of nosocomial Clostridium difficile-associated diarrhoea.
    Vonberg RP; Reichardt C; Behnke M; Schwab F; Zindler S; Gastmeier P
    J Hosp Infect; 2008 Sep; 70(1):15-20. PubMed ID: 18602185
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Treatment of Clostridium difficile-associated disease.
    Leffler DA; Lamont JT
    Gastroenterology; 2009 May; 136(6):1899-912. PubMed ID: 19457418
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Association between IgG2 and IgG3 subclass responses to toxin A and recurrent Clostridium difficile-associated disease.
    Katchar K; Taylor CP; Tummala S; Chen X; Sheikh J; Kelly CP
    Clin Gastroenterol Hepatol; 2007 Jun; 5(6):707-13. PubMed ID: 17544998
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Occurrence and treatment of Clostridium difficile-associated diarrhea].
    Tvede M; Høiby N
    Ugeskr Laeger; 2006 Jun; 168(26-32):2579; author reply 2579-80. PubMed ID: 16824400
    [No Abstract]   [Full Text] [Related]  

  • 58. Severe diarrhea and shock.
    Vora S; Glikman D; Kahanna M; Daum RS
    Pediatr Infect Dis J; 2006 Mar; 25(3):279, 284-5. PubMed ID: 16511400
    [No Abstract]   [Full Text] [Related]  

  • 59. Vancomycin therapy for severe Clostridium difficile-associated diarrhea.
    Huggan PJ; Murdoch DR
    Clin Infect Dis; 2007 Dec; 45(12):1647-8; author reply 1649-51. PubMed ID: 18190330
    [No Abstract]   [Full Text] [Related]  

  • 60. Drug evaluation: OPT-80, a narrow-spectrum macrocyclic antibiotic.
    Johnson AP
    Curr Opin Investig Drugs; 2007 Feb; 8(2):168-73. PubMed ID: 17328233
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.